Inverted internal limiting membrane flap technique for large macular holes.
Zofia Michalewska, Janusz Michalewski, Ron A Adelman...
https://pubmed.ncbi.nlm.nih.gov/20541263/Actively Recruiting
Led by Walailak University · Updated on 2026-09-09
26
Participants Needed
1
Research Sites
21 weeks
Total Duration
Researchers are evaluating a new treatment approach for people with idiopathic large macular holes, which are defects in the central retina affecting vision. This study compares the use of a decellularized human amniotic membrane hydrogel against the currently used inverted internal limiting membrane flap technique. The trial aims to assess which method better promotes hole closure and improves visual outcomes for patients with macular holes larger than 400 micrometers. Participants will undergo one of two surgical procedures involving a 25-gauge pars plana vitrectomy. One group will receive the inverted flap technique, which uses multiple small membrane flaps placed over the hole with gas tamponade. The other group will have the internal limiting membrane peeled completely and the macular hole filled with injectable amniotic membrane hydrogel, followed by gas tamponade. These methods are being studied for their anatomical success and safety over a six-month period. During the trial, participants will be closely monitored through follow-up visits over six months to assess hole closure, visual acuity, retinal layer integrity, eye pressure, and any surgical complications. Various eye imaging and vision tests will help measure these outcomes. The study includes quality checks on the hydrogel to ensure safety before use. Participants will be expected to follow postoperative care instructions, including maintaining a prone position, and attend scheduled visits to support thorough evaluation of the treatments.
CONDITIONS
Comparative Study of Decellularized Human Amniotic Membrane Hydrogel and Inverted Internal Limiting Membrane Flap in Idiopathic Large Macular Holes
J
Jakkrit Juhong, MD.
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Walailak University
Lead Sponsor
Naresuan University
Collaborating Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - 1 day
Participants undergo eye surgery using either the inverted internal limiting membrane flap technique or the amniotic membrane hydrogel filling, both followed by gas tamponade to support healing.
1 surgical procedure visit
Duration - 6 months
Participants attend follow-up visits over six months to monitor macular hole closure, visual acuity, retinal health, eye pressure, and any complications from surgery.
Regular visits at scheduled intervals during 6 months
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Zofia Michalewska, Janusz Michalewski, Ron A Adelman...
https://pubmed.ncbi.nlm.nih.gov/20541263/Jakkrit Juhong, Hathaichanok Impheng, Mukdawan Sukhang...
https://pubmed.ncbi.nlm.nih.gov/42343490/Walailak University
Lead Sponsor
Naresuan University
Collaborating Sponsor